Intra Cellular Therapies | Aset Lancar

Current Assets Perubahan Tanggal
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Cytokinetics USD 628.05M 66.63M 2023-12
Gilead Sciences USD 16.45B 474M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
Neurocrine Biosciences USD 1.65B 153.3M 2023-09
RedHill Biopharma USD 27.05M 19.47M 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12
United Therapeutics USD 3.55B 92.1M 2023-12



Intra Cellular Therapies Aset Lancar - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2024.